Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.

Hepatocellular carcinoma (HCC) surveillance rates are suboptimal. We aimed to identify HCC surveillance barriers from both physician's and patient's perspectives and assess the effectiveness of physician education using social networks. A nationwide survey with 513 physicians and another single-center survey with 315 HCC-risk patients were conducted. Barriers to suboptimal surveillance were identified using univariate and multivariate logistic regression analysis. We educated 143 physicians by sending brief notes on HCC surveillance guidelines via social networks and re-evaluated their knowledge after 60 days using t test. Surveys showed 458 (86.3%), 254 (47.8%), and 225 (42.4%) physicians recommended surveillance in patients with cirrhosis, at-risk hepatitis B virus, and hepatitis C virus infection, respectively. Only 228 (42.9%) and 241 (38.0%) respondents adhered to recommended surveillance tools and interval, respectively. The main surveillance barriers among physicians were the lack of knowledge and resource limitations. The lack of a doctor's prescription was identified as a major barrier by patient' perspectives (odds ratio 1.4, 95% CI: 1.1-1.8, P = .024). Education via social networks enhanced physicians' knowledge, with pre- and post-education scores for guideline awareness of 63.0% versus 84.3% (P < .001) and for surveillance indication and tools of 40.0% versus 63.0% (P = .001), and 42.0% versus 59.3% (P = .015), respectively. Physicians' knowledge gap is a primary barrier for adherence to HCC surveillance protocols. Brief education via social networks shows effectiveness at increasing physicians' knowledge of HCC surveillance.

[1]  J. Kramer,et al.  Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort , 2022, JAMA network open.

[2]  T. Yokoo,et al.  Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study , 2022, Alimentary pharmacology & therapeutics.

[3]  Haesuk Park,et al.  Surveillance of patients with cirrhosis remains suboptimal in the United States. , 2021, Journal of hepatology.

[4]  G. Abou-Alfa,et al.  Hepatocellular Carcinoma in Sub-Saharan Africa , 2021, JCO global oncology.

[5]  A. Movsisyan,et al.  When complexity matters: a step-by-step guide to incorporating a complexity perspective in guideline development for public health and health system interventions , 2020, BMC Medical Research Methodology.

[6]  P. Perumalswami,et al.  Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the U.S. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Jasmin A. Tiro,et al.  Patient-Reported Barriers are Associated with Receipt of Hepatocellular Carcinoma Surveillance in a Multi-Center Cohort of Patients with Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  V. Chongsuvivatwong,et al.  Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China , 2020, Cancer management and research.

[9]  J. Marrero,et al.  Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis , 2020, Hepatology.

[10]  S. Essig,et al.  The use of ultrasound in primary care: longitudinal billing and cross-sectional survey study in Switzerland , 2020, BMC Family Practice.

[11]  S. Walker,et al.  Methods to promote equity in health resource allocation in low- and middle-income countries: an overview , 2020, Globalization and Health.

[12]  R. Wong,et al.  Disparities in Hepatocellular Carcinoma Surveillance: Dissecting the Roles of Patient, Provider, and Health System Factors. , 2020, Journal of clinical gastroenterology.

[13]  M. Kumar,et al.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission , 2019, The Lancet Gastroenterology & Hepatology.

[14]  G. Francica,et al.  Status of, and strategies for improving, adherence to HCC screening and surveillance , 2019, Journal of hepatocellular carcinoma.

[15]  A. Singal,et al.  Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  Thinakorn Noree,et al.  Equity of health workforce distribution in Thailand: an implication of concentration index , 2019, Risk management and healthcare policy.

[17]  D. Ramai,et al.  Physician Awareness of Hepatocellular Carcinoma Surveillance in Patients With Chronic Liver Disease , 2018, American Journal of Gastroenterology.

[18]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[19]  S. Mohanty,et al.  Diagnosis and Management of Hepatitis C Infection in Primary Care Settings , 2018, Journal of General Internal Medicine.

[20]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[21]  R. Chaiteerakij,et al.  Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis. , 2017, Annals of hepatology.

[22]  S. Mohanty,et al.  Integrative review: patient and provider factors related to hepatocellular carcinoma surveillance in patients with liver cirrhosis , 2017 .

[23]  Jasmin A. Tiro,et al.  Patient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis , 2016, Hepatology.

[24]  P. Wilairatana,et al.  The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. , 2015, Annals of hepatology.

[25]  Sachita Shah,et al.  Perceived barriers in the use of ultrasound in developing countries , 2015, Critical Ultrasound Journal.

[26]  Teresa P. Edwards,et al.  Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  H. El‐Serag,et al.  Surveillance for hepatocellular carcinoma: can we focus on the mission? , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  Jasmin A. Tiro,et al.  Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  T. Tanwandee,et al.  Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[30]  Shigui Yang,et al.  Role of general practitioners in prevention and treatment of hepatitis B in China. , 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.

[31]  J. Kettenbach,et al.  Factors affecting screening for hepatocellular carcinoma. , 2014, Annals of hepatology.

[32]  William M. Lee,et al.  Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review , 2012, Journal of General Internal Medicine.

[33]  Sachita Shah,et al.  Review article: Use of ultrasound in the developing world , 2011, International journal of emergency medicine.

[34]  Tung T. Nguyen,et al.  Hepatitis B and Hepatocellular Carcinoma Screening Among Asian Americans: Survey of Safety Net Healthcare Providers , 2010, Digestive Diseases and Sciences.

[35]  Xianglin L. Du,et al.  Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States , 2010, Hepatology.

[36]  J. Marrero,et al.  Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis , 2009, Alimentary pharmacology & therapeutics.

[37]  Shanlian Hu,et al.  Reform of how health care is paid for in China: challenges and opportunities , 2008, The Lancet.

[38]  J. Ferrante,et al.  Family physicians' knowledge and screening of chronic hepatitis and liver cancer. , 2008, Family medicine.

[39]  E. Kluge,et al.  Resource allocation in healthcare: implications of models of medicine as a profession. , 2007, MedGenMed : Medscape general medicine.

[40]  M. Cabana,et al.  Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement , 1999 .